Tregs are well-recognised suppressors of anti-tumour effector T cell responses; CD4+ CD25+ FoxP3+ TIGIT+ Tregs were significantly elevated in the bronchoalveolar lavage fluid and peripheral blood of NSCLC patients compared to healthy control subjects [29]. The gene discussed is TIGIT; the disease is non-small cell lung carcinoma.